Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 94, Issue 1, 2001, Pages 37-45

  Bessieres M H ^a   Berrebi, A ^b   Rolland, M ^b   Bloom, M C ^b   Roques, C ^a   Cassaing, S ^a   Courjault, C ^a   Seguela J P ^a  

^a CHU RANGUEIL   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Congenital toxoplasmosis; Cord blood serology; Detection of Toxoplasma gondii; IgM and IgA antibodies; Neonatal diagnosis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PYRIMETHAMINE; SULFADOXINE;

ANTIBODY DETECTION; ARTICLE; CONGENITAL TOXOPLASMOSIS; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PARASITE ISOLATION; PLACENTA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; SEROLOGY; TOXOPLASMA GONDII; UMBILICAL CORD BLOOD;

EID: 0035178733     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00300-6     Document Type: Article

References (38)

1. Toxoplasmose conǵenitale. Bilan de la prévention primaire en France
2. La toxoplasmose chez la femme enceinte en France: Séroprévalence, taux de séroconversion et niveau de connaissance des mesures préventives. Tendances 1965-1995
3. Toxoplasmose au cours de la grossesse. Diagnostic et nouvelles possibilit́es thérapeutiques
4. Toxoplasmose conǵenitale. Etude prospective de l'issue de la grossesse chez 542 femmes atteintes de toxoplasmose acquise en cours de gestation
5. Early and longitudinal evaluation of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial
6. Toxoplasmosis
7. Etude d'une série homogène de 210 cas de toxoplasmose conǵenitale chez des nourrissons âgés de 0 à 11 mois et dépist́es de façon prospective
8. Foetopathie toxoplasmique: Traitement in utero par l'association de pyriméthamine-sulfamides
9. Long term follow up of patients with congenital ocular toxoplasmosis
10. Termination of pregnancy for maternal toxoplasmosis
11. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring
12. L'isolement du parasite dans la toxoplasmose congénitale: Intér̂et pratique et th́eorique
13. Immunoglobulin M immunosorbent agglutination assay for diagnosis of infectious diseases: Diagnosis of acute congenital and acquired toxoplasma infections
14. Determination of a new cut-off value for the diagnosis of congenital toxoplasmosis by detection of specific IgM in an enzyme immunoassay
15. IgA antibody response during acquired and congenital toxoplasmosis
16. Toxoplasmose congénitale: Dosage de prot́eines śeriques permettant un diagnostic précoce de l'infection et la prévention des complications
17. Dosage des immunoglobulines et isolement du parasite par inoculation à la souris et culture cellulaire du sang foetal: Intérêt comparatif dans le diagnostic prénatal de la toxoplasmose congénitale
18. Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid
19. Antenatal diagnosis of congenital toxoplasmosis: Evaluation of the biological parameters in a cohort of 286 patients
20. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis
21. Prenatal diagnosis of congenital toxoplasmosis in 261 pregnancies
22. Toxoplasmose congénitale: Apport du suivi biologique postnatal
23. Detection of IgA specific for toxoplasmosis in serum and cerebrospinal fluid using a non-enzymatic IgA-capture assay
24. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis
25. Early neonatal diagnosis of congenital toxoplasmosis: Value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies
26. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods
27. Développement du système immunitaire
28. Evaluation de 3 réactifs de détection par immunocapture des IgM sṕecifiques de la toxoplasmose
29. Apport du western blot au diagnostic de la toxoplasmose conǵenitale
30. La fraction C4 du comṕlement: Un nouveau marqueur indirect pour le diagnostic ańtenatal de la toxoplasmose
31. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection
32. Eye manifestations of congenital toxoplasmosis
33. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis
34. Limites du traitement ṕrenatal de la toxoplasmose conǵenitale par l'association sulfadiazine-pyriḿethamine
35. Diagnostic biologique post-natal de la Toxoplasmose cońgenitale
36. Direct and sensitive detection of a pathogen protozoan. Toxoplasma gondii, by polymerase chain reaction
37. Diagnostic anténatal de la toxoplasmose
38. Parasitemia and parasitic loads in acute infection and after anti-gamma-interferon treatment in a toxoplasmic mouse model